PMID: 9652667Jul 4, 1998Paper

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study

Lancet
A OttM M Breteler

Abstract

Previous studies suggested a protective effect of smoking on Alzheimer's disease, but most were case-control studies based on prevalent cases. The findings of prospective studies on the association between smoking and the risk of dementia are inconclusive. We did a population-based follow-up study of elderly people who were initially free of dementia. 6870 people aged 55 years and older agreed to take part. Smoking history was taken at baseline and participants were classified as never smokers, former smokers, and current smokers. During follow-up, we recorded all incident cases of dementia. We used never smokers as the reference category to calculate relative risks of dementia and Alzheimer's disease by Cox proportional hazards regression, after adjustment for age, sex, education, and alcohol intake. We also examined modification of risk by age, sex, and the apolipoprotein E (APOE) genotype. During mean follow-up of 2.1 (range 1.5-3.4) years, 146 incident cases of dementia were detected, of which 105 were Alzheimer's disease. Compared with never smokers, smokers had an increased risk of dementia (relative risk 2.2 [95% CI 1.3-3.6]) and Alzheimer's disease (2.3 [1.3-4.1]). Smoking was a strong risk factor for Alzheimer's diseas...Continue Reading

References

May 11, 1991·Lancet·P R WenhamG Blandell
Jul 1, 1991·European Journal of Epidemiology·A HofmanF A van den Ouweland
Mar 25, 1989·BMJ : British Medical Journal·R Shinton, G Beevers
Dec 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·J S MeyerK F Mortel
Mar 11, 1995·BMJ : British Medical Journal·C M van DuijnA Hofman
Oct 8, 1994·BMJ : British Medical Journal·R DollI Sutherland
Sep 1, 1994·The New England Journal of Medicine·J A Frederick
Mar 31, 1994·The New England Journal of Medicine·C E BartecchiR W Schrier
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·J PoirierS Gauthier
Jun 1, 1996·Journal of Hypertension·J M GeleijnseD E Grobbee
Oct 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·P W WilsonJ M Ordovas
Apr 1, 1998·American Journal of Epidemiology·A OttA Hofman

❮ Previous
Next ❯

Citations

Mar 14, 2007·Archives of Neurology·José A LuchsingerRichard Mayeux
Mar 29, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Gilberto LevyKaren Marder
Jun 22, 2006·Neurotoxicity Research·A Nordberg
Jul 3, 2002·Aging Clinical and Experimental Research·Arkadiusz Siennicki-LantzSölve Elmståhl
Aug 5, 2008·Journal of Neurology·S S StaekenborgP Scheltens
Dec 5, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Pinglei PanGuixiang He
Oct 24, 2007·European Journal of Epidemiology·Albert HofmanJacqueline C M Witteman
Sep 4, 2009·European Journal of Epidemiology·Albert HofmanJacqueline C M Witteman
Aug 31, 2011·European Journal of Epidemiology·Albert HofmanJacqueline C M Witteman
Dec 6, 2005·Neuropsychology Review·Michal Harciarek, Krzysztof Jodzio
Mar 19, 2008·Neuropsychology Review·Mark W BondiDavid P Salmon
May 3, 2013·International Urology and Nephrology·Rigas G KalaitzidisKostas C Siamopoulos
Aug 22, 2013·Current Neurology and Neuroscience Reports·James M NoblePanos N Papapanou
Mar 3, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Debra J Romberger, Kathleen Grant
Mar 3, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Luc LetenneurPascale Barberger-Gateau
Nov 7, 2000·The American Journal of Medicine·D Praticò, N Delanty
Dec 10, 2002·American Journal of Ophthalmology·Tien Yin WongA Richey Sharrett
Nov 15, 2000·Disease-a-month : DM·D A Bennett
May 15, 2002·European Journal of Pharmacology·Hans RommelspacherCharlotte Kloft
Sep 16, 1998·Lancet·R P FriedlandA J Lerner
Jan 1, 1999·Lancet·I SkoogK Blennow
Aug 15, 2000·Behavioural Brain Research·L Fratiglioni, H X Wang
Apr 26, 2003·Neurobiology of Aging·Suzanne L TyasLenore J Launer
Sep 6, 2000·Addictive Behaviors·M V GentryC J Meliska
Dec 5, 2002·Journal of Clinical Epidemiology·Wenyong HuangLaura Fratiglioni
May 28, 2003·Journal of Clinical Epidemiology·Gerry HillWayne Millar
Jul 10, 2003·Lancet Neurology·John T O'BrienSteven T DeKosky
Nov 4, 2009·International Psychogeriatrics·Yunhwan LeeYoun Gu Kim
May 19, 2009·Acta Pharmacologica Sinica·Wen-Hua PiaoFu-Dong Shi
Feb 10, 2011·Nature Reviews. Neurology·Christiane ReitzRichard Mayeux
Jan 5, 2000·The Australian and New Zealand Journal of Psychiatry·R StewartA Mann
Apr 4, 2001·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A BowirratA D Korczyn
Jun 12, 2009·British Medical Bulletin·Nitin Purandare
Jun 28, 2011·Brain : a Journal of Neurology·Rob A R GonsFrank-Erik de Leeuw
Nov 29, 2011·Brain : a Journal of Neurology·Monica Garcia-AllozaBrian J Bacskai

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.